| scholarly article | Q13442814 |
| P2093 | author name string | Riad Bayoumi | |
| Waad-Allah S Mula-Abed | |||
| Nafila B Al Riyami | |||
| Mohammed S Al Marhoon | |||
| Mohammed S Al Saraf | |||
| Safana S Al Saidi | |||
| Salim S Al Busaidi | |||
| P2860 | cites work | Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease | Q24632629 |
| Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer | Q26824913 | ||
| A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness | Q33839248 | ||
| Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature | Q33911725 | ||
| Biology of prostate-specific antigen | Q34170171 | ||
| The prostate health index selectively identifies clinically significant prostate cancer | Q35498981 | ||
| Are multiple markers the future of prostate cancer diagnostics? | Q35826710 | ||
| Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers | Q37238127 | ||
| Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis | Q37738370 | ||
| False-positive prostate cancer markers in a man with symptomatic urethral Chlamydia trachomatis infection | Q37845965 | ||
| The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA i | Q40267154 | ||
| Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy. | Q40295325 | ||
| Application of serum PSA to identify acute bacterial prostatitis in patients with fever of unknown origin or symptoms of acute pyelonephritis | Q40529596 | ||
| PHI in the Early Detection of Prostate Cancer. | Q48032703 | ||
| PSA forms complexes with α1-antichymotrypsin in prostate. | Q55056442 | ||
| Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer | Q78385097 | ||
| Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay | Q84029763 | ||
| Pre-analytical in-vitro stability of [-2]proPSA in blood and serum | Q84183542 | ||
| Clinical utility of %p2PSA and prostate health index in the detection of prostate cancer | Q87595258 | ||
| P433 | issue | 4 | |
| P921 | main subject | Oman | Q842 |
| biomarker | Q864574 | ||
| P304 | page(s) | 275-283 | |
| P577 | publication date | 2017-07-01 | |
| P1433 | published in | Oman Medical Journal | Q3618856 |
| P1476 | title | Validity of Prostate Health Index and Percentage of [-2] Pro-Prostate-Specific Antigen as Novel Biomarkers in the Diagnosis of Prostate Cancer: Omani Tertiary Hospitals Experience | |
| P478 | volume | 32 |
| Q90731611 | Establishment of reference intervals for serum [-2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men | cites work | P2860 |
Search more.